Construction and Characterization of an Attenuated Vaccine Vector Based on Cucumber Mosaic Virus RNA2

Plant viruses are major plant pathogens and account for nearly half of emerging plant diseases worldwide. To date, few effective management measures are available for the efficient control of plant viral diseases. Cross-protection based on attenuated vaccine is an effective strategy to prevent plant viral diseases. The primary requirement for the development of attenuated vaccines is a vector with excellent characteristics, such as low pathogenicity, genetic stability, and the capacity for stable insertion of exogenous fragments. In this study, the cucumber mosaic virus (Fny strain) was genetically modified to serve as an attenuated vaccine vector. Based on pre-termination of the 2b protein-coding region and deletion of the 3' UTR in CMV RNA2, six RNA2 mutants, designated R2-2bPTI, R2-2bPTII, R2-2bPTIII, R2-2bPTIV, R2-2bPTV, and R2-2bPTVI, were constructed. Experiments with different lengths tobacco phytoene desaturase (PDS) fragment insertion evaluated the capacity of each mutant to accommodate exogenous fragment. Based on the R2-2bPTIV, a viral fragment insertion mutant R2-2bPTIV-TMPYTVPX targeting cucumber mosaic virus (CMV), tobacco mosaic virus (TMV), potato virus Y (PVY), tobacco vein banding mosaic virus (TVBMV), and potato virus X (PVX) was constructed. This mutant provided effective cross-protection against these targeted virulent viruses. This study developed a series of CMV-based vaccine vector, providing materials and data for the development of plant viral diseases attenuated vaccines.